Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only? by Biffi, Mauro et al.
Cardiac resynchronization therapy in persistent left
superior vena cava: Can you do it two-leads-only?
Mauro Biffi, MD, Giulia Massaro, MD, Igor Diemberger, MD, PhD, Cristian Martignani, PhD,
Alessandro Corzani, MD, Matteo Ziacchi, MD, PhD
From the Istituto di Cardiologia, Policlinico S. Orsola- Malpighi, Università di Bologna, Bologna, Italy.Introduction
Persistent left superior vena cava (PLSVC) is a congenital
developmental abnormality of the sinus venosus with an
incidence of 0.47% in patients undergoing cardiac implant-
able electronic devices.1 The 2 variants include a double
superior vena cava (right and left SVC, with or without an
innominate vein connecting the two) or a single left-sided
SVC (without a right SVC), which may occur in one third of
PLSVC subjects.1 This anatomic variant may hinder pace-
maker / cardiac resynchronization therapy (CRT) device
implantation, especially when the placement of the left
ventricular (LV) lead is concerned.Case report
A 73-year-old woman with nonischemic dilated cardiomyop-
athy, NYHA class II in optimal medical therapy, severe LV
systolic dysfunction (LV ejection fraction ¼ 30%, end-
systolic volume ¼ 160 mL, end-diastolic volume ¼ 230
mL), sinus rhythm with episodes of paroxysmal atrial
fibrillation, and left bundle branch block (QRS width 160
ms) was indicated to CRT device implantation. A single
PLSVC was discovered during the implant procedure by the
course of the guide wire via a left cephalic vein access. We
report our implant technique using Protego DF-1 Pro MRI S
DX (Biotronik SE&Co KG, Berlin, Germany) right ventricle
(RV) lead, a pentapolar MR conditional implantable
cardioverter-defibrillator lead with active fixation, and a
floating atrial dipole to detect atrial signals (Figure 1). The
pentapolar lead enables a reliable P wave and atrial arrhythmia
detection,2 and thus can ensure atrioventricular synchroniza-
tion and mode switching while it simplifies the implantation
procedure by avoidance of the atrial lead, which is unneces-
sary in the absence of symptomatic sinus node disease.3 A 65-
cm active fixation ventricular lead (Protego DF-1 Pro MRI SKEYWORDS Persistent left superior vena cava; Heart failure; Cardiac
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).DX 414064, Biotronik SE&Co KG) was introduced in the
right atrium (RA) via the dilated coronary sinus (CS) from a
cephalic vein access using an 8 F peel-away (Li 8plus,
370702, Biotronik SE&Co KG). In order to cross the tricuspid
valve the stylet was shaped according to our technique,1
creating a loop into the lateral RA wall while entering the RV
(Figure 2A and B), to minimize the risk of far-field R-wave
oversensing. Both dipoles (RA and RV) showed acceptable
parameters by the customary pacing system analyzer: P-wave
amplitude was 1.6 mV, R-wave amplitude was 9 mV,
impedance was 677 ohms, and myocardial threshold was
0.5 V @ 0.4 ms. The CS was accessed via the same cephalic
vein; a venogram taken from the CS revealed a challenging
posterior coronary vein (Figure 2A and B). In order to place
the LV lead, we managed to enter the posterior vein with a
telescopic system (straight delivery system Selectra Straight-
45 375521 and subselector Selectra IC 90-59 392291,
Biotronik SE&Co KG), despite a very unstable subselector
placement and multiple dislodgements. The electrical delay
LV-RV measured by a coronary guide wire (VisionWire
352023, Biotronik SE&Co KG) was 97 ms, which is
predictive of a favorable response to CRT according to
D’Onofrio et al.4 Eventually, an active fixation LV lead was
placed (Attain Stability 20066, Medtronic Inc, Figure 2C and
D), given the high risk of LV lead dislodgement owing to the
coronary vein anatomy5,6 and to the repeated subselector
dislodgements during the procedure.
The procedure completed successfully, CRT delivery
occurred from the proximal electrode in LV-only configuration.Figure 1 Specific characteristics of the Protego DF-1 ProMRI S DX lead.
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KEY TEACHING POINTS
 Cardiac resynchronization therapy (CRT)
implantation is feasible via the left superior access
to the coronary sinus. Lead fixation can help the
difficult left ventricle lead placement.
 A pentapolar VDD lead can ensure atrial detection
without the need of a dedicated atrial lead.
 Two-lead CRT may reduce intravascular hardware
when atrial stimulation is not needed.
31Biffi et al CRT by Two Leads OnlyAt 4 months follow-up electrical parameters are reliably
good; CRT was delivered 97% of the time owing to some
premature ventricular contractions (Figure 3). Clinical
improvement and reverse remodeling have occurred: NYHA
I, LV ejection fraction ¼ 44%, end-systolic volume ¼ 95
mL, end-diastolic volume¼ 170 mL. Owing to the dedicated
algorithm for atrial sensing,2 the system effectively detectedFigure 2 A:Venogram taken from the persistent left superior vena cava showing
the high-lateral right atrial placement of the atrial sensing dipole. B: Selective ven
fixation lead placed in the posterior coronary vein chosen as target. D: Left ant
coronary vein.atrial signal (P-wave amplitude ranged from 2 to 7mV, Figure 3)
and correctly delivered CRT for 97% of beats (Figure 3).Discussion
This case highlights the potential to achieve LV lead
implantation in a challenging venous access at high risk
of lead dislodgement, as from a PLSVC, owing to the use
of dedicated tools and of an active fixation LV lead.
A pentapolar RV lead enabling P-wave detection by a
specific signal amplification and filtering process can ease
CRT implementation by the avoidance of the atrial lead
either in customary CRT implantation or in the setting of a
challenging anatomy as a PLSVC. Provided that some
limitations are to be accepted, such as lack of atrial
stimulation, this strategy helps to minimize the hardware
within the vascular system, and within the CS in the specific
situation of PLSVC. Prospective studies should compare 2-
lead vs 3-lead CRT in patients without indication to atrial
stimulation.a posterior coronary vein suitable for left ventricle (LV) lead placement. Note
ogram from the posterior vein. C: Right anterior oblique view of the active
erior oblique view of the active fixation LV lead placed inside the target
Figure 3 Long-term electrical performance of both leads at 4 months follow-up.
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